Cipla Limited Cipla Limited

Cipla Limited

CIPLA

Kedudukan dalam Saham #1814
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
Harga Saham
$14.61
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$11.81B
Perubahan (1 hari)
-0.11%
Perubahan (1 tahun)
-21.65%
Negara
IN
Perdagangan Cipla Limited (CIPLA)

Kategori

Healthcare
Sejarah pecahan saham untuk Cipla Limited (CIPLA)
Saham Cipla Limited (simbol: CIPLA) telah mengalami sejumlah 4 pecahan saham.
Pecahan saham terkini berlaku pada Apr 24, 2006.
Satu saham CIPLA yang dibeli sebelum Oct 18, 1999 kini bersamaan dengan 112.5 saham CIPLA.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
2006-04-24 5:2 x2.5 x112.5
2004-05-11 5:1 x5 x45
1999-10-21 3:1 x3 x9
1999-10-18 3:1 x3 x3
Pecahan saham untuk syarikat pesaing atau serupa